Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis

BACKGROUND: Polypharmacy, often defined as the concomitant use of ≥ 5 medications, has been identified as a significant global public health threat. Aging and multimorbidity are key drivers of polypharmacy and have been linked to a broad range of adverse health outcomes and mortality. Patients with...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Syst Rev
Glavni autori: Okpechi, Ikechi G., Tinwala, Mohammed M., Muneer, Shezel, Zaidi, Deenaz, Ye, Feng, Hamonic, Laura N., Khan, Maryam, Sultana, Naima, Brimble, Scott, Grill, Allan, Klarenbach, Scott, Lindeman, Cliff, Molnar, Amber, Nitsch, Dorothea, Ronksley, Paul, Shojai, Soroush, Soos, Boglarka, Tangri, Navdeep, Thompson, Stephanie, Tuot, Delphine, Drummond, Neil, Mangin, Dee, Bello, Aminu K.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8256607/
https://ncbi.nlm.nih.gov/pubmed/34218816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-021-01752-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items